BioAlliance Pharma announces fund raising of € 40 million

Paris, July 26, 2007 -- BioAlliance Pharma SA (Euronext Paris - Code Isin: FR0010095596 - BIO), a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics targeting drug resistance in cancer, HIV, and opportunistic infections, announces today that it has raised funds by means of a private placement, using the authorization granted by the extraordinary shareholder meeting of 24 April 2007. The gross proceeds of the share capital increase amounts to € 40 million.

More info on BioAlliance's website or on the press release